Skip to main content
. 2022 Apr 7;41:285. doi: 10.11604/pamj.2022.41.285.26952

Table 1.

characteristics and traditional risk factors of hypertensive participants attending an HIV treatment centre, northern Tanzania, 2018 (n=91)

Demographics
Age (years), mean (SD) 51.1 (11.2)
Sex (female), n (%) 75 (82.4%)
Education, n=90, n (%)
Primary school or less 75 (83.3%)
Secondary school or higher 15 (16.7%)
Income per month (USD), median (IQR) 35 (17 - 67)
HIV-related characteristics
HIV duration (months), n=85, median (IQR) 46 (18 - 82)
ART duration (months), median (IQR) 41 (18 - 72)
Current ART, n (%)
TDF, 3TC, EFV 72 (79.1%)
AZT, 3TC, NVP 9 (9.9%)
TDF, FTC, EFV 5 (5.5%)
Other 5 (5.5%)
CD4 current (cells/mm3), n=90, median (IQR) 454 (348 - 603)
CD4 nadir (cells/mm3), n=90, median (IQR) 240 (117 - 382)
HIV RNA level (copies/mL), n=80, n (%)
0 - 199 69 (86.3%)
200 - 999 2 (2.5%)
>1000 9 (11.3%)
Traditional hypertension risk factors
Family history of hypertension (yes), n=90, n (%) 36 (40.0%)
Daily fruit intake (yes), n (%) 27 (29.7%)
Daily vegetable intake (yes), n (%) 36 (39.6%)
Always add salt while cooking (yes), n (%) 76 (83.5%)
Vigorous or moderate intensity physical activity (yes), n (%) 78 (86.7%)
Smoking or tobacco use history, n (%)
Never 73 (80.2%)
Former 13 (14.3%)
Current 5 (5.5%)
Alcohol use, n (%)
Never 18 (19.8%)
Former 35 (38.5%)
Current 38 (41.8%)
Current high risk, n=38 13 (34.2%)

Sample size is 91 participants unless otherwise stated. Abbreviations: SD: standard deviation; USD: United States dollar; IQR: interquartile range; ART: antiretroviral therapy; TDF: tenofovir disoproxil fumarate; 3TC: lamivudine; EFV: efavirenz; AZT: zidovudine; NVP: nevirapine; FTC: emtricitabine; BMI: body mass index